RO91141A - PROCESS FOR THE PREPARATION OF 2-OXINOL-1-CARBOXAMIDE DERIVATIVES - Google Patents

PROCESS FOR THE PREPARATION OF 2-OXINOL-1-CARBOXAMIDE DERIVATIVES

Info

Publication number
RO91141A
RO91141A RO85118604A RO11860485A RO91141A RO 91141 A RO91141 A RO 91141A RO 85118604 A RO85118604 A RO 85118604A RO 11860485 A RO11860485 A RO 11860485A RO 91141 A RO91141 A RO 91141A
Authority
RO
Romania
Prior art keywords
oxinol
preparation
carboxamide derivatives
carboxamide
derivatives
Prior art date
Application number
RO85118604A
Other languages
French (fr)
Romanian (ro)
Other versions
RO91141B (en
Inventor
Saul B Kadin
Original Assignee
Pfizer Inc,Us
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc,Us filed Critical Pfizer Inc,Us
Publication of RO91141A publication Critical patent/RO91141A/en
Publication of RO91141B publication Critical patent/RO91141B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RO118604A 1984-05-04 1985-05-03 Process for the preparation of 2-oxindol-1-carboxamide derivatives RO91141B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60735684A 1984-05-04 1984-05-04

Publications (2)

Publication Number Publication Date
RO91141A true RO91141A (en) 1987-06-30
RO91141B RO91141B (en) 1987-07-03

Family

ID=24431933

Family Applications (2)

Application Number Title Priority Date Filing Date
RO123678A RO94455B (en) 1984-05-04 1985-05-03 Process for preparing 2-oxindol-1-carboxamide derivatives
RO118604A RO91141B (en) 1984-05-04 1985-05-03 Process for the preparation of 2-oxindol-1-carboxamide derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RO123678A RO94455B (en) 1984-05-04 1985-05-03 Process for preparing 2-oxindol-1-carboxamide derivatives

Country Status (25)

Country Link
JP (1) JPS60243068A (en)
KR (1) KR870000497B1 (en)
AR (1) AR241159A1 (en)
BG (2) BG60208B2 (en)
CS (1) CS252828B2 (en)
DD (1) DD232916A5 (en)
EG (1) EG17193A (en)
ES (2) ES8609248A1 (en)
FI (1) FI80016C (en)
HU (1) HU196057B (en)
IE (1) IE851103L (en)
IN (1) IN161509B (en)
MA (1) MA20424A1 (en)
MW (1) MW1685A1 (en)
MX (1) MX5839A (en)
NO (1) NO163132C (en)
OA (1) OA08098A (en)
PL (2) PL145416B1 (en)
PT (1) PT80375B (en)
RO (2) RO94455B (en)
RU (1) RU2017729C1 (en)
SU (1) SU1468413A3 (en)
YU (1) YU44998B (en)
ZA (1) ZA853324B (en)
ZW (1) ZW7885A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
IL95880A (en) * 1989-10-13 1995-12-31 Pfizer Use of 3-substituted-2-oxindole derivatives for the preparation of a pharmaceutical preparation for inhibiting interleukin-1 biosynthesis

Also Published As

Publication number Publication date
RO94455B (en) 1988-07-01
HUT37754A (en) 1986-02-28
MW1685A1 (en) 1986-09-10
CS252828B2 (en) 1987-10-15
YU73085A (en) 1988-04-30
FI80016C (en) 1990-04-10
PL145416B1 (en) 1988-09-30
PL257892A1 (en) 1986-10-07
BG60208B2 (en) 1993-12-30
IN161509B (en) 1987-12-19
RO94455A (en) 1988-06-30
FI851756L (en) 1985-11-05
ES8609248A1 (en) 1986-07-16
YU44998B (en) 1991-06-30
AR241159A1 (en) 1991-12-30
ZA853324B (en) 1986-12-30
CS320285A2 (en) 1987-03-12
NO163132C (en) 1990-04-11
PT80375A (en) 1985-05-01
KR850008154A (en) 1985-12-13
JPH0335315B2 (en) 1991-05-27
PL147508B1 (en) 1989-06-30
MX5839A (en) 1993-11-01
AR241159A2 (en) 1991-12-30
ZW7885A1 (en) 1985-07-24
HU196057B (en) 1988-09-28
JPS60243068A (en) 1985-12-03
DD232916A5 (en) 1986-02-12
RO91141B (en) 1987-07-03
KR870000497B1 (en) 1987-03-12
RU2017729C1 (en) 1994-08-15
EG17193A (en) 1990-08-30
NO851774L (en) 1985-11-05
MA20424A1 (en) 1985-12-31
FI80016B (en) 1989-12-29
ES551275A0 (en) 1987-07-16
BG60207B2 (en) 1993-12-30
OA08098A (en) 1987-03-31
PL253203A1 (en) 1986-06-17
IE851103L (en) 1985-11-04
ES542813A0 (en) 1986-07-16
FI851756A0 (en) 1985-05-03
PT80375B (en) 1987-09-30
NO163132B (en) 1990-01-02
SU1468413A3 (en) 1989-03-23
ES8707182A1 (en) 1987-07-16

Similar Documents

Publication Publication Date Title
RO85815A (en) PROCESS FOR THE PREPARATION OF TIAZOL DERIVATIVES
RO84584A (en) PROCESS FOR THE PREPARATION OF BENZOTIOFEN DERIVATIVES
RO95509A (en) PROCESS FOR PREPARING ANY DERIVATIVES OF 1,4-DIHYDRO-4-OXONAFTIRIDINE
RO86425A (en) PROCESS FOR THE PREPARATION OF N-PHOSPHONOMETHYLGLICINE DERIVATIVES
ES540080A0 (en) PROCEDURE FOR PREPARING NEW DERIVATIVES OF 1,3-DIHIDRO-6- (1-HIDROXI-2-DIMETILAMINOMETIL-ALIL) -7-HIDROXI-FURO- (3,4-C) -PIRIDINA
RO84456A (en) PROCESS FOR THE PREPARATION OF ANY DERIVATIVES OF SUBSTITUTED CYFALOSPORINE TIENO AND FUROPIRIDINIUM
RO90621A2 (en) PROCESS FOR PREPARATION OF 2-OXINDOL DERIVATIVES
RO85070A (en) PROCESS FOR THE PREPARATION OF N-PHENYL-CARBAMATE DERIVATIVES
RO87341A (en) PROCESS FOR THE PREPARATION OF ANY DERIVATIVES OF ARYLCYCLOBUTILALCHYLAMINE
RO89124A (en) PROCESS FOR THE PREPARATION OF CHINOLONE DERIVATIVES
RO93388A (en) PROCESS FOR THE PREPARATION OF ANIMINAL CALCIUM DERIVATIVES
RO90953A (en) PROCESS FOR THE PREPARATION OF 2-OXINOL-1-CARBOXAMIDE DERIVATIVES
RO84100A (en) PROCESS FOR THE PREPARATION OF BENZODIAZOPINE DERIVATIVES
RO89363A (en) PROCESS FOR THE PREPARATION OF CEFALOSPORINE
RO84583A (en) PROCESS FOR THE PREPARATION OF PIRANONE DERIVATIVES
RO91666A (en) PROCESS FOR THE PREPARATION OF PENOXYPROSTATRYLENIC ACID DERIVATIVES
ES542469A0 (en) PROCEDURE FOR PREPARING IMINOTIAZOLIDINIC DERIVATIVES
RO87690A (en) PROCESS FOR THE PREPARATION OF TETRAZOL DERIVATIVES
RO87039A2 (en) PROCEDURE FOR PREPARATION OF PENYLANIC ACID DERIVATIVES
RO88220A (en) PROCESS FOR THE PREPARATION OF CEFALOSPORINE DERIVATIVES
FR2562896B1 (en) PROCESS FOR THE PREPARATION OF 3-EXOMETHYLENECEPHAME DERIVATIVES
RO84457A (en) PROCESS FOR PREPARATION OF 7-BETA-AMINOXAZOLYLACETAMINE-3-CEFEM-4-CARBOXYLIC ACID DERIVATIVES
RO84200A (en) PROCESS FOR THE PREPARATION OF ALCOHLICS OF N-ARYLSULPHENYL-N-DIARYLOXYPHOSPHINYLMETHYL-GLYCINES
RO82680A (en) PROCESS FOR THE PREPARATION OF 11-HYDRO-O-13-OOAPROSTAGLANDINE DERIVATIVES
RO91141A (en) PROCESS FOR THE PREPARATION OF 2-OXINOL-1-CARBOXAMIDE DERIVATIVES